お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:再生医療の市場規模:技術、用途、地域別 - シェア、見通し、機会分析(2020年~2027年)
市場調査レポート
商品コード
968757

再生医療の市場規模:技術、用途、地域別 - シェア、見通し、機会分析(2020年~2027年)

Regenerative Medicine Market, by Technology, by Application, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 176 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.72円
再生医療の市場規模:技術、用途、地域別 - シェア、見通し、機会分析(2020年~2027年)
出版日: 2021年02月17日
発行: Coherent Market Insights
ページ情報: 英文 176 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

再生医療は、心血管疾患、皮膚創傷、および特定のタイプの癌の治療など、慢性疾患と急性疾患の両方の治療に有用です。また、現在の臓器および組織移植はドナーからの供給に限られており、患者を死に至らしめたり、免疫系に重篤な合併症をもたらすことが多くあります。再生医療は、このような問題を大幅に軽減するのに役立ちます。ただし、高いコストは再生医療市場の成長を妨げています。

当レポートは、世界の再生医療市場について調査しており、市場の動向や機会、成長および抑制要因、技術・用途・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査目的・前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの概要
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場内訳:技術別
    • 市場内訳:用途別
  • Coherent Opportunity Map (COM)

第3章 市場力学、規制、および動向分析

  • 市場力学
    • 成長要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • PEST分析
  • COVID-19影響分析

第4章 市場分析:技術別(2016-2027)

  • イントロダクション
  • 幹細胞
  • 生体材料
  • ヒト組織工学

第5章 市場分析:用途別(2016-2027)

  • イントロダクション
  • 骨移植代替物
  • 骨関節疾患
  • 同種骨
  • 自家骨
  • その他

第6章 市場分析:地域別(2016-2027)

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東
  • アフリカ

第7章 競合情勢

  • 企業プロファイル
    • Anika Therapeutics, Inc.
    • Arthrex, Inc.
    • Baxter International, Inc.
    • CONMED Corporation
    • DePuy Synthes, Inc.
    • Medtronic, Plc
    • Smith & Nephew plc
    • Stryker Corporation
    • Zimmer Holdings, Inc.
    • Aziyo Biologics
    • Ortho Regenerative Technologies Inc.

第8章 セクション

目次

Title:
Regenerative Medicine (Bone and Joint) Market, by Technology (Stem Cell, Biomaterial, and Tissue Engineering), by Application (Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Bones, Autogenic Bones, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Regenerative medicine is a biological heterogeneous domain that incorporates material science, engineering, medicine, biological science, and surgery. It acts therapeutically by augmenting and stimulating the body's capacity for regeneration and self-repair. Regenerative medicine involves the development of methods to regrow, repair or replace either the damaged or diseased cells, organs or tissues. This medicinal branch includes the generation and usage of stem cells and tissue engineering.

Moreover, Major players in the market are also focused on expanding their capabilities. For instance, in March 2020, BioStem Life Sciences, a subsidiary of BioStem Technologies Inc. and a developer of regenerative therapies, announced to add R&D laboratory to its Florida, U.S. facility.

Market Dynamics

Key companies focusing on product approvals in regenerative medicine is expected to drive the global regenerative medicine (Bone and Joint) market growth. For instance, in 2017, Karl Schumacher Dental, LLC launched its new range of regenerative products, which include allograft, xenograft, and synthetic and collagen membranes.

Moreover, adoption of 3D printing technology in regenerative medicine (bone and joint) is expected to aid in growth of the global regenerative medicine (bone and joint) market. For instance, in February 2020, researchers from Wake Forest School of Medicine, U.S. reported investigation of the effects of neural cell integration into the bioprinted skeletal muscle construct to accelerate functional muscle regeneration in vivo.

Furthermore, High prevalence of arthritis is expected to propel growth of the global regenerative medicine (bone and joint) market over the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC)'s May 2019 report, around 54.4 million U.S. adults had diagnosed arthritis, which accounted for around 1 in 4 people in the U.S.

Key features of the study:

  • This report provides in-depth analysis of the global regenerative medicine (bone and joint) market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2020-2027)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, regional outlook, and competitive strategies adopted by the leading players.
  • It profiles leading players in the global regenerative medicine (bone and joint) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansions and marketing tactics
  • The global regenerative medicine (bone and joint) market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
  • The key players operating in global regenerative medicine (Bone and Joint) market include Anika Therapeutics, Inc, Arthrex, Inc., Baxter International, Inc., CONMED Corporation, Johnson & Johnson, Medtronic, Plc, Smith & Nephew plc, Stryker Corporation, Zimmer Holdings, Inc., Aziyo Biologics, and Ortho Regenerative Technologies Inc.
  • Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global regenerative medicine (bone and joint) market

Detailed Segmentation:

  • Global Regenerative Medicine (Bone and Joint) Market, By Technology :
    • Stem Cell
    • Biomaterial
    • Tissue Engineering
  • Global Regenerative Medicine (Bone and Joint) Market, By Application :
    • Bone Graft Substitutes
    • Osteoarticular Diseases
    • Allogeneic Bones
    • Autogenic Bones
    • Others
  • Global Regenerative Medicine (Bone and Joint) Market, By Region:
    • North America
      • By Technology:
      • Stem Cell
      • Biomaterial
      • Tissue Engineering
      • By Application :
      • Bone Graft Substitutes
      • Osteoarticular Diseases
      • Allogeneic Bones
      • Autogenic Bones
      • Others
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Technology:
      • Stem Cell
      • Biomaterial
      • Tissue Engineering
      • By Application :
      • Bone Graft Substitutes
      • Osteoarticular Diseases
      • Allogeneic Bones
      • Autogenic Bones
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Technology:
      • Stem Cell
      • Biomaterial
      • Tissue Engineering
      • By Application :
      • Bone Graft Substitutes
      • Osteoarticular Diseases
      • Allogeneic Bones
      • Autogenic Bones
      • Others
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Technology:
      • Stem Cell
      • Biomaterial
      • Tissue Engineering
      • By Application :
      • Bone Graft Substitutes
      • Osteoarticular Diseases
      • Allogeneic Bones
      • Autogenic Bones
      • Others
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Technology:
      • Stem Cell
      • Biomaterial
      • Tissue Engineering
      • By Application :
      • Bone Graft Substitutes
      • Osteoarticular Diseases
      • Allogeneic Bones
      • Autogenic Bones
      • Others
      • By Country/Region:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Technology:
      • Stem Cell
      • Biomaterial
      • Tissue Engineering
      • By Application :
      • Bone Graft Substitutes
      • Osteoarticular Diseases
      • Allogeneic Bones
      • Autogenic Bones
      • Others
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Anika Therapeutics, Inc.*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Arthrex, Inc.
    • Baxter International, Inc.
    • CONMED Corporation
    • Johnson & Johnson
    • Medtronic, Plc
    • Smith & Nephew plc
    • Stryker Corporation
    • Zimmer Holdings, Inc.
    • Aziyo Biologics
    • Ortho Regenerative Technologies Inc

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

  • Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations
  • Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Technology
  • Market Snippet, By Application
  • Market Snippet, By Region
  • Coherent Opportunity Map (COM)
  • Market Dynamics, Regulations, and Trends Analysis
  • Drivers
  • Restraints
  • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • PEST Analysis
  • Global Regenerative Medicine (Bone and Joint) Market, Impact of COVID-19 Pandemic
  • COVID-19 Epidemiology
  • Impact of Covid-19 on Clinical Trials
  • Government Initiatives
  • Global Regenerative Medicine (Bone and Joint) Market, By Technology, 2016 - 2027, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017- 2027
  • Segment Trends
    • Stem Cell
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
    • Biomaterial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
    • Tissue Engineering
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
  • Global Regenerative Medicine (Bone and Joint) Market, By Application, 2016-2027 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017- 2027
  • Segment Trends
    • Bone Graft Substitutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
    • Osteoarticular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
    • Allogeneic Bones
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
    • Allogeneic Bones
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2027, (US$ Mn)
  • Global Regenerative Medicine (Bone and Joint) Market, By Region, 2016-2027 (US$ Mn)
  • Introduction
  • Market Share Analysis, By Country, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, For Countries, 2017-2027
  • North America
  • Introduction
  • Market Size and Forecast, By Technology, 2020-2027 (US$ Mn)
  • Market Size and Forecast, By Application, 2020-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2020-2027 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, By Technology, 2020-2027 (US$ Mn)
  • Market Size and Forecast, By Application, 2020-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2020-2027 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, By Technology, 2020-2027 (US$ Mn)
  • Market Size and Forecast, By Application, 2020-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2020-2027 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, By Technology, 2020-2027 (US$ Mn)
  • Market Size and Forecast, By Application, 2020-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2020-2027 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, By Technology, 2020-2027 (US$ Mn)
  • Market Size and Forecast, By Application, 2020-2027 (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2020-2027 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, By Technology, 2020-2027 (US$ Mn)
  • Market Size and Forecast, By Application, 2020-2027 (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2020-2027 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa
  • Competitive Landscape
  • Company Profiles
  • Anika Therapeutics, Inc
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Arthrex, Inc.
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Baxter International, Inc.
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • CONMED Corporation
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Johnson & Johnson
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Medtronic, Plc
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Smith & Nephew plc
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Stryker Corporation
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Zimmer Holdings, Inc.
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Aziyo Biologics
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Ortho Regenerative Technologies Inc.
  • Company Overview
  • Clinical Trial Phase Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.